ゲノム編集の世界市場分析:技術別(CRISPR、TALEN、ZFN)、送達方法別(体外、体内)、用途別(動物/植物細胞の編集)、サービス別(インハウス、委託)、エンドユーザー別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Genome Editing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Success in pre-clinical models drives demands for genome editing therapeutics
3.1.1.2 Rising competition amongst market participants for business development
3.1.1.3 Easy editing solutions for development of therapeutics for broad range of diseases
3.1.1.4 Increasing demand for synthetic genes and genetically modified organisms
3.1.1.5 Technological advancements in gene editing technologies
3.1.1.6 Rising adoption in agricultural biotechnology
3.1.2 Market Restraint Analysis
3.1.2.1 Challenges with respect to clinical translation
3.1.2.2 Regulatory, scientific, and ethical challenges pertaining to the use of gene modified products
3.1.2.3 Off-target effects of CRISPR technology
3.2 Penetration & Growth Prospect Mapping for Technology, 2015
3.3 Molecular scissors / genome editing -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Molecular Scissors / Genome Editing Technologies: Pipeline Analysis
3.5.1 Sangamo
3.5.2 Cellectis
3.5.3 Calyxt
3.5.4 bluebird bio
3.5.5 Editas Medicine
3.5.6 Intellia Therapeutics, Inc.
3.5.7 CRISPR THERAPEUTICS
3.5.8 Precision Biosciences
3.5.9 Precision Biosciences (Non medical domain)
3.5.10 Caribou Biosciences
3.5.11 Cibus
3.5.12 Recombinetics, Inc
3.6 Intellectual Property
3.7 Regulatory Issues
3.7.1 Orphan diseases
3.7.2 Germline editing
3.7.3 Safety issues
Chapter 4 Genome Editing Market: Technology Estimates & Trend Analysis
4.1 Molecular Scissors/ Genome Editing Market: Technology Movement Analysis
4.2 Molecular Scissors / Genome Editing Technology Comparison
4.3 (CRISPR)/Cas9
4.3.1 Global (CRISPR)/Cas9 market, 2014 – 2025 (USD Million)
4.4 TALENs/MegaTALs
4.4.1 Global TALENs/MegaTALs market, 2014 – 2025 (USD Million)
4.5 ZFN
4.5.1 Global ZFN market, 2014 – 2025 (USD Million)
4.6 Other Technologies
4.6.1 Global other technologies market, 2014 – 2025 (USD Million)
Chapter 5 Genome Editing Market: Delivery Method Estimates & Trend Analysis
5.1 Molecular Scissors/ Genome Editing Market: Delivery Method Movement Analysis
5.1.1 Comparison of Delivery Methods
5.1.1.1 Viral delivery
5.1.1.1.1 AAV (Adeno Associated Virus).
5.1.1.1.2 IDLV (Integrase Deficient Lentivirus).
5.1.1.2 Non-viral delivery
5.1.1.2.1 Lipid Mediated
5.1.1.2.2 Electroporation
5.2 Ex-vivo
5.2.1 Global ex-vivo delivery market, 2014 – 2025 (USD Million)
5.3 In-vivo
5.3.1 Global in-vivo delivery market, 2014 – 2025 (USD Million)
Chapter 6 Genome Editing Market: Application Estimates & Trend Analysis
6.1 Molecular Scissors / Genome Editing Market: Application Movement Analysis
6.2 Cell Line Engineering
6.2.1 Global cell line engineering market, 2014 – 2025 (USD Million)
6.3 Animal Genetic Engineering
6.3.1 Global animal genetic engineering market, 2014 – 2025 (USD Million)
6.4 Plant Genetic Engineering
6.4.1 Global plant genetic engineering market, 2014 – 2025 (USD Million)
6.5 Others
6.5.1 Global other applications market, 2014 – 2025 (USD Million)
Chapter 7 Genome Editing Market: End-use Estimates & Trend Analysis
7.1 Molecular Scissors / Genome Editing Market: End-use Movement Analysis
7.2 Biotechnology & Pharmaceutical Companies
7.2.1 Global biotechnology & pharmaceutical companies market, 2014 – 2025 (USD Million)
7.3 Academic & Government Research Institutes
7.3.1 Global academic & government research institutes market, 2014 – 2025 (USD Million)
7.4 Contract Research Organizations (CROs)
7.4.1 Global CROs market, 2014 – 2025 (USD Million)
Chapter 8 Genome Editing Market: Service Estimates & Trend Analysis
8.1 Molecular scissors / genome editing Market: Service Movement Analysis
8.2 In-house
8.2.1 Global in-house gene editing market, 2014 – 2025 (USD Million)
8.3 Contract
8.3.1 Global contract gene editing services market, 2014 – 2025 (USD Million)
Chapter 9 Genome Editing Market: Regional Estimates & Trend Analysis, by Technology, Delivery Method, Application, End-use, & Service
9.1 Molecular Scissors / Genome Editing Market Share By Region, 2015 & 2025
9.2 North America
9.2.1 North America molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S molecular scissors / genome editing culture market, 2014 – 2025 (USD Million)
9.2.3 Canada
9.2.3.1 Canada molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.3 Europe
9.3.1 Europe molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.3.2 Germany
9.3.2.1 Germany molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.3.3 UK
9.3.3.1 UK molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.4.2 Japan
9.4.2.1 Japan molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.4.3 China
9.4.3.1 China molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.5 Latin America
9.5.1 Latin America molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa molecular scissors / genome editing market, 2014 – 2025 (USD Million)
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.1.1 Genome editing companies are developing products in a range of markets
10.1.2 Genome Editing Companies are targeting a variety of markets of various sizes
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 Merck KGaA
10.3.1.1 Company overview
10.3.1.1.1 Sigma-Aldrich Co. LLC
10.3.1.2 Financial performance
10.3.1.2.1 Financial performance
10.3.1.3 Product benchmarking
10.3.1.4 Strategic initiatives
10.3.2 Cibus
10.3.2.1 Company overview
10.3.2.1.1 Nucelis
10.3.2.2 Financial performance
10.3.2.2.1 Financial performance
10.3.2.3 Product benchmarking
10.3.2.4 Strategic initiatives
10.3.3 Recombinetics, Inc
10.3.3.1 Company overview
10.3.3.2 Financial performance
10.3.3.3 Product benchmarking
10.3.3.4 Strategic initiatives
10.3.4 Sangamo
10.3.4.1 Company overview
10.3.4.2 Financial performance
10.3.4.3 Product benchmarking
10.3.4.4 Strategic initiatives
10.3.5 Editas Medicine
10.3.5.1 Company overview
10.3.5.2 Financial performance
10.3.5.3 Product benchmarking
10.3.5.4 Strategic initiatives
10.3.6 Precision Biosciences
10.3.6.1 Company overview
10.3.6.2 Financial performance
10.3.6.3 Product benchmarking
10.3.6.4 Strategic initiatives
10.3.7 CRISPR THERAPEUTICS
10.3.7.1 Company overview
10.3.7.2 Financial performance
10.3.7.3 Product benchmarking
10.3.7.4 Strategic initiatives
10.3.8 Intellia Therapeutics, Inc.
10.3.8.1 Company overview
10.3.8.2 Financial performance
10.3.8.3 Product benchmarking
10.3.8.4 Strategic initiatives
10.3.9 Caribou Biosciences, Inc
10.3.9.1 Company overview
10.3.9.2 Financial performance
10.3.9.3 Product benchmarking
10.3.9.4 Strategic initiatives
10.3.10 Cellectis
10.3.10.1 Company overview
10.3.10.1.1 Calyxt
10.3.10.2 Financial performance
10.3.10.2.1 Financial performance (Calyxt)
10.3.10.3 Product benchmarking
10.3.10.4 Strategic initiatives
10.3.11 AstraZeneca
10.3.11.1 Company overview
10.3.11.2 Financial performance
10.3.11.3 Product benchmarking
10.3.11.4 Strategic initiatives
10.3.12 Takara Bio USA
10.3.12.1 Company overview
10.3.12.2 Financial performance
10.3.12.3 Product benchmarking
10.3.12.4 Strategic initiatives
10.3.13 Horizon Discovery Group plc
10.3.13.1 Company overview
10.3.13.2 Financial performance
10.3.13.3 Product benchmarking
10.3.13.4 Strategic initiatives
10.3.14 Integrated DNA Technologies, Inc.
10.3.14.1 Company overview
10.3.14.2 Financial performance
10.3.14.3 Product benchmarking
10.3.15 Egenesis Inc.
10.3.15.1 Company overview
10.3.15.2 Financial performance
10.3.15.3 Product benchmarking
10.3.16 GenScript
10.3.16.1 Company overview
10.3.16.2 Financial performance
10.3.16.3 Product benchmarking
10.3.16.4 Strategic initiatives
10.3.17 New England Biolabs
10.3.17.1 Company overview
10.3.17.2 Financial performance
10.3.17.3 Product benchmarking
10.3.17.4 Strategic initiatives
10.3.18 OriGene Technologies, Inc.
10.3.18.1 Company overview
10.3.18.2 Financial performance
10.3.18.3 Product benchmarking
10.3.18.4 Strategic initiatives
10.3.19 bluebird bio, Inc.
10.3.19.1 Company overview
10.3.19.1.1 Precision Genome Engineering, Inc. (Pregenen)
10.3.19.2 Financial performance
10.3.19.2.1 Financial performance
10.3.19.3 Product benchmarking
10.3.19.4 Strategic initiatives
10.3.20 Lonza
10.3.20.1 Company overview
10.3.20.2 Financial performance
10.3.20.3 Product benchmarking
10.3.20.4 Strategic initiatives
10.3.21 Thermo Fisher Scientific, Inc.
10.3.21.1 Company overview
10.3.21.2 Financial performance
10.3.21.3 Product benchmarking
10.3.21.4 Strategic initiatives


【レポート販売概要】

■ タイトル:ゲノム編集の世界市場分析:技術別(CRISPR、TALEN、ZFN)、送達方法別(体外、体内)、用途別(動物/植物細胞の編集)、サービス別(インハウス、委託)、エンドユーザー別、セグメント予測、2014-2025
■ 英文:Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014-2025
■ 発行日:2017年2月10日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707356
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。